These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31795352)

  • 1. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
    Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protopanaxadiol aglycone ginsenoside-polyethylene glycol conjugates: synthesis, physicochemical characterizations, and in vitro studies.
    Mathiyalagan R; Kim YJ; Wang C; Jin Y; Subramaniyam S; Singh P; Wang D; Yang DC
    Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1803-1809. PubMed ID: 26539976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
    Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
    Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2.
    Li P; Zhou X; Qu D; Guo M; Fan C; Zhou T; Ling Y
    Drug Deliv; 2017 Nov; 24(1):834-845. PubMed ID: 28532223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
    Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
    Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
    Nag M; Gajbhiye V; Kesharwani P; Jain NK
    Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studies.
    Mathiyalagan R; Subramaniyam S; Kim YJ; Kim YC; Yang DC
    Carbohydr Polym; 2014 Nov; 112():359-66. PubMed ID: 25129755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Proteomics Combined with Affinity MS Revealed the Molecular Mechanism of Ginsenoside Antitumor Effects.
    Wang Z; Kim U; Jiao Y; Li C; Guo Y; Ma X; Jiang M; Jiang Z; Hou Y; Bai G
    J Proteome Res; 2019 May; 18(5):2100-2108. PubMed ID: 30860844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells).
    Nahar J; Boopathi V; Murugesan M; Rupa EJ; Yang DC; Kang SC; Mathiyalagan R
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor Ginsenoside Rg2 and Rh1 Attenuates LPS-Induced Acute Liver and Kidney Damages via Downregulating Activation of TLR4-STAT1 and Inflammatory Cytokine Production in Macrophages.
    Huynh DTN; Baek N; Sim S; Myung CS; Heo KS
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of chitosan polyethylene glycol antibody complex for delivery of Imatinib in lung cancer cell lines.
    Kamali M; Jafari H; Taati F; Mohammadnejad J; Daemi A
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23787. PubMed ID: 39072816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer.
    Dai L; Wang L; Deng L; Liu J; Lei J; Li D; He J
    Sci Rep; 2014 Jul; 4():5871. PubMed ID: 25070490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside-Rh1 and Rh2 inhibit the induction of nitric oxide synthesis in murine peritoneal macrophages.
    Park YC; Lee CH; Kang HS; Kim KW; Chung HT; Kim HD
    Biochem Mol Biol Int; 1996 Nov; 40(4):751-7. PubMed ID: 8950033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia
    Chen Y; Zhang Y; Song W; Zhang Y; Dong X; Tan M
    Anticancer Agents Med Chem; 2019; 19(13):1633-1641. PubMed ID: 31272362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells.
    An IS; An S; Kwon KJ; Kim YJ; Bae S
    Oncol Rep; 2013 Feb; 29(2):523-8. PubMed ID: 23152132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
    Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
    Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.